Device Trial Radar · NCT06389071
Laser Treatment for Lichen Sclerosus
Last checked: Nov 20, 2026Latest source record: Apr 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Mar 1, 2024
Primary completion
Jul 20, 2027
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- ScitonNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 29, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Fractional ablative laser treatment for Lichen Sclerosus lesion
Conditions
- Lichen Sclerosus Lesion
Interventions
Fractional 2940 nm LaserDevice
Fractional 2940 nm Laser
Primary outcomes
What the sponsor says the trial is designed to measure.
- Histological clearanceTime frame: 16 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clinique Medicale Uro-Gyneco de l'Abitibi
Val-d'Or, Quebec, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.